IL107040A0 - Modified platelet factor-4 - Google Patents

Modified platelet factor-4

Info

Publication number
IL107040A0
IL107040A0 IL107040A IL10704093A IL107040A0 IL 107040 A0 IL107040 A0 IL 107040A0 IL 107040 A IL107040 A IL 107040A IL 10704093 A IL10704093 A IL 10704093A IL 107040 A0 IL107040 A0 IL 107040A0
Authority
IL
Israel
Prior art keywords
platelet factor
mpf
cpf
potent
modified platelet
Prior art date
Application number
IL107040A
Other languages
English (en)
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of IL107040A0 publication Critical patent/IL107040A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/521—Chemokines
    • C07K14/522—Alpha-chemokines, e.g. NAP-2, ENA-78, GRO-alpha/MGSA/NAP-3, GRO-beta/MIP-2alpha, GRO-gamma/MIP-2beta, IP-10, GCP-2, MIG, PBSF, PF-4, KC
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Detergent Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Materials For Medical Uses (AREA)
IL107040A 1992-09-25 1993-09-20 Modified platelet factor-4 IL107040A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US95279792A 1992-09-25 1992-09-25

Publications (1)

Publication Number Publication Date
IL107040A0 true IL107040A0 (en) 1993-12-28

Family

ID=25493243

Family Applications (1)

Application Number Title Priority Date Filing Date
IL107040A IL107040A0 (en) 1992-09-25 1993-09-20 Modified platelet factor-4

Country Status (24)

Country Link
US (3) US5512550A (xx)
EP (1) EP0589719B1 (xx)
JP (1) JPH06220091A (xx)
KR (1) KR940007059A (xx)
CN (1) CN1035257C (xx)
AT (1) ATE151777T1 (xx)
AU (1) AU665114B2 (xx)
BR (1) BR9303903A (xx)
CA (1) CA2106629A1 (xx)
CZ (1) CZ195193A3 (xx)
DE (1) DE69309827T2 (xx)
DK (1) DK0589719T3 (xx)
ES (1) ES2101237T3 (xx)
FI (1) FI934183A (xx)
GR (1) GR3023356T3 (xx)
HK (1) HK100597A (xx)
HU (1) HUT69928A (xx)
IL (1) IL107040A0 (xx)
MX (1) MX9305901A (xx)
MY (1) MY109158A (xx)
NO (1) NO933423L (xx)
NZ (1) NZ248724A (xx)
YU (1) YU61893A (xx)
ZA (1) ZA936925B (xx)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL107040A0 (en) * 1992-09-25 1993-12-28 Lilly Co Eli Modified platelet factor-4
IL113561A0 (en) * 1994-05-09 1995-08-31 Lilly Co Eli Expression of recombinant mpf-4, cpf-4, pf-4 and precursor compounds
US5994292A (en) * 1995-05-31 1999-11-30 The United States Of America As Represented By The Department Of Health And Human Services Interferon-inducible protein 10 is a potent inhibitor of angiogenesis
JPH09143199A (ja) * 1995-11-17 1997-06-03 Nippon Chem Res Kk 血小板第４因子の製造方法
CN101307106B (zh) * 1995-12-13 2013-06-12 儿童医学中心公司 内皮细胞增殖抑制剂及其应用方法
FR2774990B1 (fr) * 1998-02-16 2000-07-28 Inst Vaisseaux Et Du Sang Nouveaux peptides, utilisation en therapeutique et compositions pharmaceutiques les renfermant
PT1427427E (pt) 2001-09-12 2011-09-13 Sigma Tau Res Switzerland Sa Derivados de glicosaminoglicanos parcialmente dessulfatados como inibidores da heparanase, dotados de actividade antiangiogénica e destituídos de efeito anticoagulante
EP1812468A2 (en) * 2004-09-15 2007-08-01 K.U.Leuven Research & Development Platelet factor 4 variant 1 (pf4var1) related inhibitors of angiogenesis
CN114805536B (zh) * 2022-06-24 2022-09-02 北京百臻生物技术有限公司 一种人血小板因子4蛋白突变体及其应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4737580A (en) * 1985-03-15 1988-04-12 Oncogen Platelet related growth regulator
US4645828A (en) * 1984-03-23 1987-02-24 Oncogen Platelet related growth regulator
US4844895A (en) * 1985-11-01 1989-07-04 New York University Composition containing a peptide fragment of platelet factor four and method for restoring suppressed immune responses
NZ218634A (en) * 1985-12-20 1991-06-25 Oncogen Peptide identified by its cross reactivity with a cell growth factor, dna, antibodies to peptide and test kits
AU1539188A (en) * 1987-05-04 1988-11-10 Bristol-Myers Squibb Company TGF-B2 and novel compositions having anti-neoplastic activity
US5086164A (en) * 1989-01-10 1992-02-04 Repligen Corporation Novel methods and compositions for treatment of angiogenic diseases
US5187075A (en) * 1989-01-26 1993-02-16 Sri International Cloning and expression of a variant gene of platelet factor 4 and compositions thereof to modulate immune responses
US5112946A (en) * 1989-07-06 1992-05-12 Repligen Corporation Modified pf4 compositions and methods of use
EP0423641A3 (en) * 1989-10-18 1992-01-15 Nippon Mining Company Limited Expression vector, transformed microorganism, fusion protein and method for the production of platelet factor 4 or tgfalpha
WO1992002240A2 (en) * 1990-07-27 1992-02-20 Repligen Corporation Novel methods and compositions for treatment of angiogenic diseases
IL107040A0 (en) * 1992-09-25 1993-12-28 Lilly Co Eli Modified platelet factor-4

Also Published As

Publication number Publication date
ES2101237T3 (es) 1997-07-01
CA2106629A1 (en) 1994-03-26
MX9305901A (es) 1994-05-31
DK0589719T3 (da) 1997-09-08
FI934183A0 (fi) 1993-09-24
ATE151777T1 (de) 1997-05-15
DE69309827D1 (de) 1997-05-22
YU61893A (sh) 1996-02-19
US5512550A (en) 1996-04-30
ZA936925B (en) 1995-03-20
NZ248724A (en) 1995-10-26
AU665114B2 (en) 1995-12-14
CZ195193A3 (en) 1994-04-13
HK100597A (en) 1997-08-08
GR3023356T3 (en) 1997-08-29
JPH06220091A (ja) 1994-08-09
HUT69928A (en) 1995-09-28
EP0589719A1 (en) 1994-03-30
NO933423L (no) 1994-03-28
FI934183A (fi) 1994-03-26
CN1088216A (zh) 1994-06-22
US5538949A (en) 1996-07-23
HU9302687D0 (en) 1993-12-28
NO933423D0 (no) 1993-09-24
EP0589719B1 (en) 1997-04-16
KR940007059A (ko) 1994-04-26
US5935928A (en) 1999-08-10
AU4757393A (en) 1994-03-31
BR9303903A (pt) 1994-06-14
CN1035257C (zh) 1997-06-25
DE69309827T2 (de) 1997-08-28
MY109158A (en) 1996-12-31

Similar Documents

Publication Publication Date Title
ATE82858T1 (de) N-terminale fragmente von menschlichem serumalbumin.
EP0259475A4 (en) RECOMBINANT HUMAN ENDOTHEL CELL GROWTH FACTOR.
HK1010790A1 (en) Adheson variants
DE69029406D1 (en) Polypeptid
DE3770915D1 (de) Menschliches apolipoprotein a1 sowie dessen variante, exprimiert in escherichia coli.
HU9302687D0 (en) Modified blood plaque-factor-4
EP0446315A4 (en) Recombinant product
BR9007115A (pt) Novo trombolitico
HU895788D0 (en) Process for producing peptides and medical products containing them
ATE143974T1 (de) Peptide des hiv-gag proteins, ihre herstellung und verwendung
AU637589B2 (en) Ancrod proteins, their production and use
RU93054511A (ru) Тромбоцитарные факторы, фармацевтическая композиция, способ получения тромбоцитарных факторов, днк, вектор, клетка